Investing US$1 billion to bring 2 to 4 new antimicrobials to patients by 2030.
The AMR Action Fund is a groundbreaking VC fund that enables breakthroughs in the development of antibiotics, anti-fungals, and other antimicrobials. We invest in companies developing innovative treatments for priority drug-resistant pathogens and advocate for market reforms and policy solutions to change how society values these lifesaving drugs.
investing, investment, healthcare, biotech, research and development, pharmaceutical, antibiotics, antimicrobial resistance, AMR, venture capital, and private equity
Aiming to overcome technical and funding barriers in antibiotic development and ensuring a sustainable pipeline of new antibiotics to fight superbugs.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Seventure Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Seventure Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 25 Apr 2023 | | |
Roche Pharmaceutical, Biotechnology, Biotechnology Research | Roche Pharmaceutical, Biotechnology, Biotechnology Research | Other 18 Nov 2022 | | |
United Nations Academic Impact International development, International Affairs | United Nations Academic Impact International development, International Affairs | Other 13 Dec 2023 | |